Enfusion, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 174.54 million compared to USD 150.35 million a year ago. Net income was USD 6.03 million compared to net loss of USD 7.65 million a year ago.

Basic earnings per share from continuing operations was USD 0.07 compared to basic loss per share from continuing operations of USD 0.1 a year ago. Diluted earnings per share from continuing operations was USD 0.07 compared to diluted loss per share from continuing operations of USD 0.1 a year ago.